Fisher & Paykel Healthcare dodges worst of US tariff risk: Jarden

Fisher & Paykel Healthcare dodges worst of US tariff risk: Jarden
About 43% of Fisher & Paykel Healthcare’s revenue comes from the US. (Image: Supplied)
John Anthony
Jarden has raised its rating and target share price for Fisher & Paykel Healthcare by 10%, as Thursday’s US tariff announcements proved less damaging than expected.Following US President Donald Trump’s unveiling of “Liberation Day” tariffs, shares in Fisher & Paykel Healthcare (FPH), a company with significant export exposure to the US, traded as low as $32.60 in the wake of the announcement on Thursday. They were currently at $34.80.In a research note released late Thursday evening, Jarden analysts Adrian Allbon...

More Economy

How to Be Wrong: summer reading for the PM
Economy

How to Be Wrong: summer reading for the PM

Advice on leading for innovation, threats to democracy, gangs, and more.

Pattrick Smellie 28 Nov 2025
RBNZ officials not against more transparency, just cautious
Economy

RBNZ officials not against more transparency, just cautious

The key is that any changes add value, says Assistant Governor Karen Silk.

Rebecca Howard 28 Nov 2025
‘Looking up’: Recovery taking hold as business confidence hits 11-year high
Economy

‘Looking up’: Recovery taking hold as business confidence hits 11-year high

Business confidence jumped another nine points from 58 to 67 in November, the highest level in 11 years, the ANZ Business Outlook survey for November shows.“Things are looking up!” said ANZ chief economist Sharon Zollner.“Out of a hole, admittedly,” she added.When interpreting qu...

Staff reporters 27 Nov 2025
Rodger Finlay new RBNZ chair, Rhiannon McKinnon to board
Economy

Rodger Finlay new RBNZ chair, Rhiannon McKinnon to board

Finlay is expected to deliver increased accountability and transparency.

Rebecca Howard 27 Nov 2025